相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study
Alice Canzian et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase
Marco Caminati et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine
Ian D. Pavord et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?
Florie Akdime et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
M. E. Wechsler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
Vincent Cottin et al.
AUTOIMMUNITY REVIEWS (2017)